Search Within

Center for Pancreatic Cancer Research

Formats
  1. Journal Article (5057)
  2. Meeting Abstract (2483)
  3. Book Section (225)
  4. Review (220)
  5. Editorial (135)
  6. Conference Paper (75)
  7. Correspondence (48)
  8. Research Letter (43)
  9. Miscellaneous (41)
  10. Guidelines (38)
  11. Book Whole (20)
Groups
  1. Department of Medicine (3942)
  2. Solid Tumor Oncology Division (3242)
  3. Surgery (3165)
  4. GSK Faculty (2910)
  5. Epidemiology and Biostatistics (2524)
  6. Gastrointestinal Oncology Service (2297)

More Groups

People
  1. Mithat Gonen (1034)
  2. William Jarnagin (911)
  3. Eileen O'Reilly (795)
  4. Michael D'Angelica (787)
  5. T Peter Kingham (620)
  6. David Kelsen (538)

More People

Years
  1. 2025 (286)
  2. 2024 (497)
  3. 2023 (523)
  4. 2022 (602)
  5. 2021 (555)
  6. 2020 (562)

More Years

Publications
  1. Journal of Clinical Oncology (927)
  2. Annals of Surgical Oncology (395)
  3. Cancer Research (226)
  4. International Journal of Radiation Oncology, Biology, Physics (219)
  5. Laboratory Investigation (209)
  6. Modern Pathology (191)

More Publications

Publishers
  1. American Society of Clinical Oncology (1002)
  2. Springer (840)
  3. Elsevier Inc. (757)
  4. Nature Publishing Group (632)
  5. American Association for Cancer Research (551)
  6. Elsevier Science, Inc. (510)

More Publishers

Results (8385)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinical and translational results from REVOLUTION cohorts A (nivolumab + ipilimumab + chemotherapy) and B (hydroxychloroquine + ipilimumab + chemotherapy) in patients with previously untreated metastatic pancreatic adenocarcinoma
    Meeting Abstract

    O'Reilly, E. M.; Wainberg, Z. A.; Fisher, G. A. Jr; Wolff, R. A.; Ko, A. H.; O'Hara, M. H.; Spencer, C. N.; Yu, J. X.; Da Silva, D. M.; Padron, L. J.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • AMPLIFY-7P, a first-in-human safety and efficacy trial of adjuvant mKRAS-specific lymph node targeted amphiphile ELI-002 7P vaccine in patients with minimal residual disease-positive pancreatic and colorectal cancer
    Meeting Abstract

    Devoe, C. E.; Pant, S.; Wainberg, Z. A.; Chung, V.; George, T. J.; Kasi, P. M.; VanWyk, H.; Tavares, A.; Perry, J.; Kheoh, T.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Avutometinib/defactinib and gemcitabine/nab-paclitaxel combination in first-line metastatic pancreatic ductal adenocarcinoma: Initial safety and efficacy of phase 1b/2 study (RAMP 205)
    Meeting Abstract

    Lim, K. H.; Spencer, K. R.; Safyan, R. A.; Picozzi, V. J.; Varghese, A. M.; Siolas, D.; Perez, K.; Clift, S.; Denis, L. J.; Bhambhani, V.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Alliance EAY191-A6: FOLFOX in combination with binimetinib as second-line therapy for patients with advanced biliary tract cancers (BTCs) with MAPK pathway alterations: A ComboMATCH treatment trial
    Meeting Abstract

    Shergill, A.; Liao, C. Y.; Elsaid, M. I.; Al Baghdadi, T.; Ji, Y.; Feldman, D.; George, S.; O'Reilly, E. M.; Meyerhardt, J. A.; Berg, S. A.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Phase I/II first-in-human study to evaluate the safety and efficacy of tissue factor-ADC MRG004A in patients with solid tumors
    Meeting Abstract

    Park, W.; Zhang, J.; Dayyani, F.; Shan, J.; Liu, R.; Guo, R.; O'Reilly, E. M.; Liu, Z.; Gao, S.; Wu, X.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Achieving World Health Organization Global Breast Cancer Initiative targets: A situational analysis and action plan in Nigeria
    Meeting Abstract

    Romanoff, A.; Olasehinde, O.; Okereke, C. E.; Agodirin, O. S.; Ali, N.; Irowa, O.; Muhammad, A. B.; Nweke, N. S.; Wuraola, F. O.; Owoade, I. A.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Durvalumab and stereotactic ablative body radiotherapy (SABR) in locally advanced (LA) and borderline resectable (BR) pancreatic cancer (PDAC): Long-term outcomes and correlative insights
    Meeting Abstract

    Keane, F.; Tuli, R.; O'Connor, C. A.; Schwartz, C.; Park, W.; Varghese, A. M.; Perry, M.; Singhal, A.; Vardhana, S.; Hendifar, A. E.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Does non-alcoholic fatty liver disease increase the risk for pancreatic cancer? A multi-center retrospective cohort study
    Meeting Abstract

    Singh, R. R.; O'Reilly, E. M.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Intra-treatment hypoxia directed major radiation de-escalation as definitive treatment for human papillomavirus-related oropharyngeal cancer
    Meeting Abstract

    Lee, N. Y.; Sherman, E. J.; Schòˆder, H.; Wray, R.; White, C.; Dunn, L.; Hung, T.; Pfister, D. G.; Ho, A. L.; McBride, S. M.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Prescribers of opioids for head and neck cancer (HNC) survivors
    Meeting Abstract

    Salz, T.; Meza, A. M.; Bradshaw, P. T.; Jinna, S.; Moryl, N.; Kriplani, A.; Tringale, K. R.; Flory, J.; Korenstein, D.; Lipitz-Snyderman, A.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save